Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
primary studies published RCT
Details- 2009
- Chapman I
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.
primary studies published RCT
Details- 2009
- Dauletbaev N
Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status.
primary studies published RCT
Details- 2009
- Dogru D
Pulmonary delivery of tobramycin by an investigational EFlow electronic nebulizer saves 50% of the drug, and results in equivalent or improved tobramycin safety levels in plasma and sputum [abstract].
primary studies published RCT
Details- 2009
- Griese M
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis.
primary studies published RCT
Details- 2009
- Jacquemin E
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
primary studies published RCT
Details- 2009
- Khazai NB
Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?.
primary studies published RCT
Details- 2009
- Loeve M
Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
primary studies published RCT
Details- 2009
- Moran A